142 related articles for article (PubMed ID: 24980853)
1. Ultrastructure of cytoplasmic and nuclear inosine-5'-monophosphate dehydrogenase 2 "rods and rings" inclusions.
Juda P; Smigová J; Kováčik L; Bártová E; Raška I
J Histochem Cytochem; 2014 Oct; 62(10):739-50. PubMed ID: 24980853
[TBL] [Abstract][Full Text] [Related]
2. Development of a recombinant cell-based indirect immunofluorescence assay (RC-IFA) for the determination of autoantibodies against "rings and rods"-associated inosine-5'-monophosphate dehydrogenase 2 in viral hepatitis C.
Probst C; Radzimski C; Blöcker IM; Teegen B; Bogdanos DP; Stöcker W; Komorowski L
Clin Chim Acta; 2013 Mar; 418():91-6. PubMed ID: 23333419
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies against inosine-5'-monophosphate dehydrogenase 2--characteristics and prevalence in patients with HCV-infection.
Seelig HP; Appelhans H; Bauer O; Blüthner M; Hartung K; Schranz P; Schultze D; Seelig CA; Volkmann M
Clin Lab; 2011; 57(9-10):753-65. PubMed ID: 22029192
[TBL] [Abstract][Full Text] [Related]
4. Mycobacterium tuberculosis IMPDH in Complexes with Substrates, Products and Antitubercular Compounds.
Makowska-Grzyska M; Kim Y; Gorla SK; Wei Y; Mandapati K; Zhang M; Maltseva N; Modi G; Boshoff HI; Gu M; Aldrich C; Cuny GD; Hedstrom L; Joachimiak A
PLoS One; 2015; 10(10):e0138976. PubMed ID: 26440283
[TBL] [Abstract][Full Text] [Related]
5. The conformation of NADH bound to inosine 5'-monophosphate dehydrogenase determined by transferred nuclear Overhauser effect spectroscopy.
Schalk-Hihi C; Zhang YZ; Markham GD
Biochemistry; 1998 May; 37(20):7608-16. PubMed ID: 9585576
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of inosine 5'-monophosphate dehydrogenase by the antiviral agent 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide 5'-monophosphate.
Wang W; Papov VV; Minakawa N; Matsuda A; Biemann K; Hedstrom L
Biochemistry; 1996 Jan; 35(1):95-101. PubMed ID: 8555204
[TBL] [Abstract][Full Text] [Related]
7. Induction of cytoplasmic rods and rings structures by inhibition of the CTP and GTP synthetic pathway in mammalian cells.
Carcamo WC; Satoh M; Kasahara H; Terada N; Hamazaki T; Chan JY; Yao B; Tamayo S; Covini G; von Mühlen CA; Chan EK
PLoS One; 2011; 6(12):e29690. PubMed ID: 22220215
[TBL] [Abstract][Full Text] [Related]
8. A novel variant L263F in human inosine 5'-monophosphate dehydrogenase 2 is associated with diminished enzyme activity.
Wang J; Zeevi A; Webber S; Girnita DM; Addonizio L; Selby R; Hutchinson IV; Burckart GJ
Pharmacogenet Genomics; 2007 Apr; 17(4):283-90. PubMed ID: 17496727
[TBL] [Abstract][Full Text] [Related]
9. Assembly of IMPDH2-based, CTPS-based, and mixed rod/ring structures is dependent on cell type and conditions of induction.
Keppeke GD; Calise SJ; Chan EK; Andrade LE
J Genet Genomics; 2015 Jun; 42(6):287-99. PubMed ID: 26165495
[TBL] [Abstract][Full Text] [Related]
10. ANKRD9 is a metabolically-controlled regulator of IMPDH2 abundance and macro-assembly.
Hayward D; Kouznetsova VL; Pierson HE; Hasan NM; Guzman ER; Tsigelny IF; Lutsenko S
J Biol Chem; 2019 Sep; 294(39):14454-14466. PubMed ID: 31337707
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase and differentiation induction of K562 cells among the mycophenolic acid derivatives.
Mitsuhashi S; Takenaka J; Iwamori K; Nakajima N; Ubukata M
Bioorg Med Chem; 2010 Nov; 18(22):8106-11. PubMed ID: 20934342
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of novel inosine 5'-monophosphate dehydrogenase (IMPDH) inhibitors.
Dunkern T; Chavan S; Bankar D; Patil A; Kulkarni P; Kharkar PS; Prabhu A; Goebel H; Rolser E; Burckhard-Boer W; Arumugam P; Makhija MT
J Enzyme Inhib Med Chem; 2014 Jun; 29(3):408-19. PubMed ID: 23663081
[TBL] [Abstract][Full Text] [Related]
13. IMPDH2 forms spots at branching sites and distal ends of astrocyte stem processes.
Toyoda S; Handa T; Yong H; Takahashi H; Shiwaku H
Genes Cells; 2024 Feb; 29(2):150-158. PubMed ID: 38009721
[TBL] [Abstract][Full Text] [Related]
14. NAD-based inhibitors with anticancer potential.
Felczak K; Vince R; Pankiewicz KW
Bioorg Med Chem Lett; 2014 Jan; 24(1):332-6. PubMed ID: 24269162
[TBL] [Abstract][Full Text] [Related]
15. Ribavirin induces widespread accumulation of IMP dehydrogenase into rods/rings structures in multiple major mouse organs.
Keppeke GD; Calise SJ; Chan EKL; Andrade LEC
Antiviral Res; 2019 Feb; 162():130-135. PubMed ID: 30605724
[TBL] [Abstract][Full Text] [Related]
16. Cofactor-type inhibitors of inosine monophosphate dehydrogenase via modular approach: targeting the pyrophosphate binding sub-domain.
Felczak K; Chen L; Wilson D; Williams J; Vince R; Petrelli R; Jayaram HN; Kusumanchi P; Kumar M; Pankiewicz KW
Bioorg Med Chem; 2011 Mar; 19(5):1594-605. PubMed ID: 21324702
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolic acid inhibits oleic acid-induced mesangial cell activation through both cellular reactive oxygen species and inosine monophosphate dehydrogenase 2 pathways.
Huh KH; Ahn HJ; Park J; Ju MK; Song JS; Kim MS; Kim SI; Kim YS
Pediatr Nephrol; 2009 Apr; 24(4):737-45. PubMed ID: 19093139
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of inosine 5'-monophosphate dehydrogenase type II mediates chemoresistance to human osteosarcoma cells.
Fellenberg J; Kunz P; Sähr H; Depeweg D
PLoS One; 2010 Aug; 5(8):e12179. PubMed ID: 20808934
[TBL] [Abstract][Full Text] [Related]
19. Effects of inosine monophosphate dehydrogenase inhibition on high glucose-induced cellular reactive oxygen species in mesangial cells.
Song JS; Huh KH; Park J; Ju MK; Kim MS; Kim YS
Transplant Proc; 2008 Mar; 40(2):464-6. PubMed ID: 18374103
[TBL] [Abstract][Full Text] [Related]
20. Highly selective inhibition of IMPDH2 provides the basis of antineuroinflammation therapy.
Liao LX; Song XM; Wang LC; Lv HN; Chen JF; Liu D; Fu G; Zhao MB; Jiang Y; Zeng KW; Tu PF
Proc Natl Acad Sci U S A; 2017 Jul; 114(29):E5986-E5994. PubMed ID: 28674004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
